We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Chemical Triggers Breast Cancer

By Biotechdaily staff writers
Posted on 21 Jul 2005
An estrogen-mimicking chemical has been found to be a potent trigger of breast cancer. More...


The chemical, 4-nonylphenol (4-NP), is released into the environment from plastics, cleaning materials, textiles, and some paper. The chemical has also been found in drinking water and some processed foods. It stimulates an enzyme system in the liver that increases the production of estriol, a hormone associated with breast cancer. The chemical's affinity for estrogen receptors in breast tissue is 4,000 times less than that of estrogen.

In comparing the effects of various doses of 4-NP and estrogen on mice, researchers discovered that while 4-NP stimulates estriol metabolism in the liver, it does not lead to increased levels of estriol in the bloodstream. They concluded that as well as stimulating enzymes that produce estriol, 4-NP also has a direct inhibiting effect on estriol production. In a second experiment, the researchers gave doses of 4-NP to mice genetically engineered to readily develop breast cancer. Over a 32-week period, many of these mice developed breast cancer. Those given equivalent doses of estrogen, based on the relative binding affinities of 4-NP and estradiol for their receptors, did not develop mammary cancer.

"Long term exposure to 4-nonylphenol could leave individuals at a significantly increased risk of developing breast cancer,” concluded toxicologist William Baldwin, from the University of Texas, El Paso (USA), a member of the research team. The findings were reported in the July 12, 2005, online edition of the Journal of Applied Toxicology (Wiley InterScience).


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Aspiration System
VACUSAFE
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.